Skip to content
10-Q

Quarterly Report

Evommune, Inc. EVMN

0001193125-25-315972

← back to feed
Filed
Dec 11, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Dec 10, 2025 31.52M sh
Shares Diluted Q3 2025 · Sep 30, 2025 1.55M sh
Shares Diluted Q3 2025 · Sep 30, 2025 1.54M sh
Shares Diluted Q3 2025 · Sep 30, 2024 1.52M sh
Shares Diluted Q3 2025 · Sep 30, 2024 1.5M sh
Capex Q3 2025 · Sep 30, 2025 $131K
Capex Q3 2025 · Sep 30, 2024 $88K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$59.74M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$39.68M
Short Term Investments Q3 2025 · Sep 30, 2025 $49.24M
Short Term Investments Q3 2025 · Dec 31, 2024 $55.79M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $26.82M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $16.26M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $18.15M
Stockholders Equity Q3 2025 · Sep 30, 2025 −$183.14M
Stockholders Equity Q3 2025 · Jun 30, 2025 −$171.23M
Stockholders Equity Q3 2025 · Dec 31, 2024 −$144.24M
Stockholders Equity Q3 2025 · Sep 30, 2024 −$122.53M
Stockholders Equity Q3 2025 · Jun 30, 2024 −$107.03M
Stockholders Equity Q3 2025 · Dec 31, 2023 −$77.71M
Current Liabilities Q3 2025 · Sep 30, 2025 $10.42M
Current Liabilities Q3 2025 · Dec 31, 2024 $27.98M
Total Liabilities Q3 2025 · Sep 30, 2025 $10.68M
Total Liabilities Q3 2025 · Dec 31, 2024 $28.52M
Current Assets Q3 2025 · Sep 30, 2025 $81.94M
Current Assets Q3 2025 · Dec 31, 2024 $73.99M
Total Assets Q3 2025 · Sep 30, 2025 $84.54M
Total Assets Q3 2025 · Dec 31, 2024 $76.06M
Eps Diluted Q3 2025 · Sep 30, 2025 −$8.07
Eps Diluted Q3 2025 · Sep 30, 2025 −$26.36
Eps Diluted Q3 2025 · Sep 30, 2024 −$10.47
Eps Diluted Q3 2025 · Sep 30, 2024 −$30.69
Eps Basic Q3 2025 · Sep 30, 2025 −$8.07
Eps Basic Q3 2025 · Sep 30, 2025 −$26.36
Eps Basic Q3 2025 · Sep 30, 2024 −$10.47
Eps Basic Q3 2025 · Sep 30, 2024 −$30.69
Sga Expense Q3 2025 · Sep 30, 2025 $3.69M
Sga Expense Q3 2025 · Sep 30, 2025 $10.72M
Sga Expense Q3 2025 · Sep 30, 2024 $3.23M
Sga Expense Q3 2025 · Sep 30, 2024 $9.15M
Rd Expense Q3 2025 · Sep 30, 2025 $19.64M
Rd Expense Q3 2025 · Sep 30, 2025 $53.64M
Rd Expense Q3 2025 · Sep 30, 2024 $13.29M
Rd Expense Q3 2025 · Sep 30, 2024 $46.41M
Net Income Q3 2025 · Sep 30, 2025 −$12.48M
Net Income Q3 2025 · Sep 30, 2025 −$40.6M
Net Income Q3 2025 · Sep 30, 2024 −$15.92M
Net Income Q3 2025 · Sep 30, 2024 −$46.08M
Operating Income Q3 2025 · Sep 30, 2025 −$13.33M
Operating Income Q3 2025 · Sep 30, 2025 −$51.36M
Operating Income Q3 2025 · Sep 30, 2024 −$16.52M
Operating Income Q3 2025 · Sep 30, 2024 −$48.56M
Revenue Q3 2025 · Sep 30, 2025 $10M
Revenue Q3 2025 · Sep 30, 2025 $13M
Revenue Q3 2025 · Sep 30, 2024 $7M